reading tendon threads from 2024 and half of it aged badly
reading tendon threads from 2024 and half of it aged badly — a position I have arrived at slowly and would like tested.
Regulatory classification differs between jurisdictions and has changed in several of them recently. Any answer to a status question needs a place and a date attached.
Paid for identity confirmation rather than just purity for the first time here. Worth it, and it is not the default on most certificates.
Ask for the theoretical mass alongside the measured one. It is a one-line addition to a certificate and it converts a purity claim into an identity claim.
Happy to answer the boring questions. Those are usually the ones worth asking.
best — the order this archive was captured in
It is a fifteen-residue peptide with a published sequence, which makes synthesis straightforward and makes identity verification the meaningful test rather than an optional extra.
Not convinced. A high purity figure with no identity confirmation tells you the sample is homogeneous, not that it is what you ordered.
Not convinced.
This is the point that should be at the top of every thread here. Identity first.
The published literature is overwhelmingly preclinical, largely in rodent models. Translating a rodent result into a human expectation is not a small step, and almost every confident claim here takes it silently.
Not convinced.
Agreed — and the preclinical to clinical gap is where nearly all the overclaiming happens.
a fifteen-residue peptide is easy to make and easy to make badly
Small fix — fifteen residues, not seventeen. The sequence is public and easy to check.
Small fix — fifteen residues, not seventeen.
mariam_mensa is right that a pure something-else is still something else.
Agreed. Identity is the question here. A short peptide can be synthesised by almost anyone and the sequence is what you are actually buying.
Every claim I could trace in this board went back to about four papers. That was a sobering afternoon.
Standing reminder in every thread here: research material is not approved for human use.
That claim traces back to a single preclinical paper that says something considerably narrower.
I would not extrapolate a mechanism from a model system to a person in one step, which is what that comment does.
Short peptides in solution are subject to hydrolysis and, depending on sequence, oxidation. Storage state and time in solution are practical variables that this board almost never discusses.
Bought small, tested identity first, and only then thought about anything else. That order felt right.
What method produced that purity number?
Disagree — that is a rodent study and you are stating it as a human effect. The distance between those is the entire argument.
ask for the mass spectrum, not just the purity number
Purity by area percent tells you the sample is homogeneous. Mass spectrometry tells you what the homogeneous thing is. For a short peptide, the second question is the one worth paying for.
Reconstituted or powder, and how long has it been in solution?
Correction: that study was in rodents. Worth stating explicitly since the thread has been reading it as clinical.
Assumed regulatory status was static and it was not. Checked again this year and the answer had changed where I live.
Assumed regulatory status was static and it was not.
Disagreeing with this line: that paper is in a rodent model and it is being quoted as a human result.
read the actual papers, they are more modest than the summaries
That is a purity figure, not an identity confirmation. Two different tests and only one answers the question asked.
the tendon claims are the most repeated and the least evidenced
Careful. Regulatory status differs by jurisdiction and has changed; a confident global statement is going to be wrong somewhere.
This. Mass spectrometry for identity, not just an area percent, because a pure something-else is still something else.
Kept a reconstituted vial too long out of curiosity and learned something about solution stability I would rather have read.
- 1Purity by area percent tells you the sample is homogeneous. Mass…8 comments in this branch · started by u/elodie_yilmaz
- 2Not convinced. A high purity figure with no identity confirmation tells you…7 comments in this branch · started by u/canada_coverage